199 related articles for article (PubMed ID: 36948674)
1. Integrating Surgery in the Multidisciplinary Care of Advanced Renal Cell Carcinoma.
Ray S; Dason S; Singer EA
Urol Clin North Am; 2023 May; 50(2):311-323. PubMed ID: 36948674
[TBL] [Abstract][Full Text] [Related]
2. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.
Karam JA; Wood CG
Hematol Oncol Clin North Am; 2011 Aug; 25(4):753-64. PubMed ID: 21763966
[TBL] [Abstract][Full Text] [Related]
3. Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma: A Review.
Ghoreifi A; Vaishampayan U; Yin M; Psutka SP; Djaladat H
JAMA Oncol; 2024 Feb; 10(2):240-248. PubMed ID: 38095885
[TBL] [Abstract][Full Text] [Related]
4. [Role of surgery (cytoreductive nephrectomy and metastasectomy) in the management of metastatic renal cell carcinoma: a literature review].
Arroua F; Maurin C; Carcenac A; Ragni E; Rossi D; Bastide C
Prog Urol; 2010 Dec; 20(13):1175-83. PubMed ID: 21130395
[TBL] [Abstract][Full Text] [Related]
5. The evolving role of surgery for advanced renal cell carcinoma in the era of molecular targeted therapy.
Rini BI; Campbell SC
J Urol; 2007 Jun; 177(6):1978-84. PubMed ID: 17509276
[TBL] [Abstract][Full Text] [Related]
6. Integration of surgery and systemic therapy for renal cell carcinoma.
Kenney PA; Wood CG
Urol Clin North Am; 2012 May; 39(2):211-31, vii. PubMed ID: 22487764
[TBL] [Abstract][Full Text] [Related]
7. Is cytoreductive nephrectomy relevant in the immunotherapy era?
Singla N; Ghandour RA; Margulis V
Curr Opin Urol; 2019 Sep; 29(5):526-530. PubMed ID: 31305273
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant and neoadjuvant therapy for renal cell carcinoma: a survey of the Society of Urologic Oncology.
Tobert CM; Uzzo RG; Wood CG; Lane BR
Urol Oncol; 2013 Oct; 31(7):1316-20. PubMed ID: 22264501
[TBL] [Abstract][Full Text] [Related]
9. The role of metastasectomy in renal cell carcinoma in the era of targeted therapy.
Ljungberg B
Curr Urol Rep; 2013 Feb; 14(1):19-25. PubMed ID: 23212738
[TBL] [Abstract][Full Text] [Related]
10. Evolving Role of Urologists in the Management of Advanced Renal Cell Carcinoma.
Kapoor A; Kim J; Goucher G; Hoogenes J
Urol Clin North Am; 2020 Aug; 47(3):271-280. PubMed ID: 32600530
[TBL] [Abstract][Full Text] [Related]
11. Multimodal treatment of advanced renal cancer in 2017.
Mennitto A; Verzoni E; Grassi P; Ratta R; Fucà G; Procopio G
Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1395-1402. PubMed ID: 28956645
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
Kwan KG; Kapoor A
Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
[TBL] [Abstract][Full Text] [Related]
13. Surgery of locally advanced and metastatic kidney cancer after tyrosine kinase inhibitors therapy: single institute experience.
De Gobbi A; Biasoni D; Catanzaro M; Nicolai N; Piva L; Stagni S; Torelli T; Procopio G; Verzoni E; Grassi P; Colecchia M; Paolini B; Spreafico C; Marchianò A; Salvioni R
Tumori; 2018 Oct; 104(5):388-393. PubMed ID: 28085177
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease.
Wood CG; Margulis V
Cancer; 2009 May; 115(10 Suppl):2355-60. PubMed ID: 19402066
[TBL] [Abstract][Full Text] [Related]
15. Urologic approaches to metastatic renal cell carcinoma.
Mickisch GH
Onkologie; 2001 Apr; 24(2):122-6. PubMed ID: 11441290
[TBL] [Abstract][Full Text] [Related]
16. [The value of tumor nephrectomy in metastatic renal cell carcinoma].
Scheepe JR; Mickisch GH
Urologe A; 2002 May; 41(3):221-4. PubMed ID: 12132270
[TBL] [Abstract][Full Text] [Related]
17. Evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma of variant histology.
Alhalabi O; Karam JA; Tannir NM
Curr Opin Urol; 2019 Sep; 29(5):521-525. PubMed ID: 31305271
[TBL] [Abstract][Full Text] [Related]
18. Role of cytoreductive nephrectomy in renal cell carcinoma.
Chiong E; Wood CG; Margulis V
Future Oncol; 2009 Aug; 5(6):859-69. PubMed ID: 19663735
[TBL] [Abstract][Full Text] [Related]
19. Cytoreductive nephrectomy vs medical therapy as initial treatment: a rational approach to the sequence question in metastatic renal cell carcinoma.
Spiess PE; Fishman MN
Cancer Control; 2010 Oct; 17(4):269-78. PubMed ID: 20861814
[TBL] [Abstract][Full Text] [Related]
20. Cytoreductive nephrectomy in metastatic clear-cell renal cell carcinoma: perspectives in the tyrosine kinase inhibitor era.
Biswas S; Kelly J; Eisen T
Oncologist; 2009 Jan; 14(1):52-9. PubMed ID: 19147692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
